Discover the future of biomedical research with LunaGel™, an innovative 3D cell culture platform by Gelomics. Join Dr. Christoph Meinert, CEO of Gelomics, for an exclusive seminar exploring how LunaGel™ is revolutionizing the creation of realistic human tissue models—bridging the gap between traditional cell culture systems and cutting-edge research.
Learn how LunaGel™ empowers researchers with:
- Scalable and ethical alternatives to traditional cell culture and animal testing
- Enhanced precision and control over experimental conditions
- Predictive and physiologically relevant models for drug development, disease research, and tissue engineering
Dr. Meinert will also highlight exciting opportunities to engage with Gelomics as partners for projects, grants, internships, and career development.
Whether you’re a student, researcher, or industry professional, this seminar offers invaluable insights into advancing your work with the latest innovations in 3D cell culture. Don’t miss the opportunity to elevate your research!
Speaker Bio: Dr. Christoph Meinert, MAICD
Dr. Christoph Meinert, Co-Founder and CEO of Gelomics, is a recipient of 18 awards for research excellence, including the QUT Outstanding PhD Thesis Award (top 5%) and the Siganto Foundation Medal. Since earning his Ph.D. in 2017, he has authored 50+ peer-reviewed publications, including in prestigious journals like Advanced Materials and Nature Protocols, earning over 2,800 citations, an h-index of 24, and a Field-Weighted Citation Impact of 2.36. Over 80% of his work is published in the top 25% of journals globally. Dr. Meinert has also secured $12M+ in R&D and venture capital, led the development of 17 globally distributed products, and, as CEO since March 2023, grown Gelomics into a thriving biotech company operating in 23 international markets.